Format

Send to

Choose Destination
See comment in PubMed Commons below
Ann N Y Acad Sci. 2007 Oct;1114:56-68. Epub 2007 Oct 12.

Mechanisms of action of TGF-beta in cancer: evidence for Smad3 as a repressor of the hTERT gene.

Author information

  • 1Department of Immunology, AMREP, Monash Medical School, Commercial Road, Prahran, Victoria 3181, Australia. he.li@med.monash.edu.au.

Abstract

Transforming growth factor-beta (TGF-beta) induces cell differentiation and suppresses cell proliferation, but the mechanisms underlying the actions of TGF-beta remain to be fully elucidated. Recent studies suggest that TGF-beta suppresses neoplastic cell development by employing Smad3 protein to repress the gene of human telomerase reverse transcriptase (hTERT). In human breast cancer cells, TGF-beta induces rapid phosphorylation and subsequent entry of Smad3 into the nucleus. In the nucleus, Smad3 binds to the hTERT gene promoter directly and inhibits hTERT gene transcription activity. By interacting with c-myc, Smad3 also represses the c-myc gene. Thus, TGF-beta prevents continuous cell proliferation by switching off telomerase activity through Smad3 repression of the hTERT gene and the action of c-myc. Modulating the interface between Smad3 and the hTERT gene, and the potential feedback loop from telomeres to Smad3 via Smurf2, may represent a novel approach to regulate cell lifespan of proliferation.

PMID:
17934056
DOI:
10.1196/annals.1396.016
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Wiley
    Loading ...
    Support Center